- Home
- TGL vs QNRX Comparison
TGL vs QNRX Comparison
Compare TGL & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TGL
- QNRX
- Stock Information
- Founded
- TGL 2020
- QNRX 2018
- Country
- TGL United States
- QNRX United States
- Employees
- TGL N/A
- QNRX N/A
- Industry
- TGL Retail: Computer Software & Peripheral Equipment
- QNRX Medical/Dental Instruments
- Sector
- TGL Technology
- QNRX Health Care
- Exchange
- TGL Nasdaq
- QNRX Nasdaq
- Market Cap
- TGL 4.1M
- QNRX 4.3M
- IPO Year
- TGL 2022
- QNRX N/A
- Fundamental
- Price
- TGL $0.73
- QNRX $7.78
- Analyst Decision
- TGL
- QNRX
- Analyst Count
- TGL 0
- QNRX 0
- Target Price
- TGL N/A
- QNRX N/A
- AVG Volume (30 Days)
- TGL 1.2M
- QNRX 2.6K
- Earning Date
- TGL 09-26-2025
- QNRX 11-06-2025
- Dividend Yield
- TGL N/A
- QNRX N/A
- EPS Growth
- TGL N/A
- QNRX N/A
- EPS
- TGL N/A
- QNRX N/A
- Revenue
- TGL $1,468,790.00
- QNRX N/A
- Revenue This Year
- TGL N/A
- QNRX N/A
- Revenue Next Year
- TGL N/A
- QNRX N/A
- P/E Ratio
- TGL N/A
- QNRX N/A
- Revenue Growth
- TGL N/A
- QNRX N/A
- 52 Week Low
- TGL $0.81
- QNRX $5.01
- 52 Week High
- TGL $76.50
- QNRX $54.95
- Technical
- Relative Strength Index (RSI)
- TGL 31.36
- QNRX 55.82
- Support Level
- TGL $0.81
- QNRX $7.39
- Resistance Level
- TGL $1.41
- QNRX $7.74
- Average True Range (ATR)
- TGL 0.17
- QNRX 0.17
- MACD
- TGL -0.06
- QNRX 0.10
- Stochastic Oscillator
- TGL 2.67
- QNRX 100.00
About TGL Treasure Global Inc.
Treasure Global Inc has created an online-to-offline e-commerce platform business model offering consumers and merchants instant rebates and affiliate cashback programs, while providing a seamless e-payment solution with rebates in both e-commerce and physical retailers/merchant settings. Its product is an internet application branded ZCITY app, that targets consumers by providing personalized deals based on consumers' purchase history, location and preferences.
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.